NCT00001524View on ClinicalTrials.gov

Thalidomide to Treat Oral Lesions in HIV-Infected Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

June 30, 1996

Study Completion Date

December 31, 2004

Conditions
Acquired Immunodeficiency SyndromeBurning Mouth SyndromeHIV Infection
Interventions
DRUG

Thalidomide

Trial Locations (1)

20892

National Institute of Dental And Craniofacial Research (NIDCR), Bethesda

All Listed Sponsors
lead

National Institute of Dental and Craniofacial Research (NIDCR)

NIH

NCT00001524 - Thalidomide to Treat Oral Lesions in HIV-Infected Patients | Biotech Hunter | Biotech Hunter